Currently, the 7 antiobesity medications (AOMs) approved by the FDA to treat obesity are phentermine, orlistat, phentermine/topiramate extended release (ER), naltrexone sustained release (SR)/bupropion SR, liraglutide (3.0 mg), semaglutide (2.4 mg), and tirzepatide
They can also be found in blood vessels, in the peripheral nervous system, in the joints, the lungs, the heart, the alpha cells of the pancreas, and in the kidneys, giving them many different functions in the body: activating a protein here, lowering a different protein there, playing a role in intricate paths of cause and effect, getting things done
Moyano D, Vilaseca MA, Artuch R, Lambruschini N
FOUNDAYO INDICATION AND SAFETY SUMMARY WITH WARNINGS Foundayo (fown-DAY-oh) is a prescription medicine used with a reduced-calorie diet and increased physical activity to help adults with obesity, or some adults with overweight who also have weight-related medical problems, to lose excess body weight and keep the weight off
This article has been updated to add the vote on semax.
Michael Phelps Founder & Peptide Research Specialist, PrymaLab Published January 15, 2025 Updated May 18, 2026 ~14 min read Quick Answer What is bacteriostatic water used for in peptide science